Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process.

Pharmacist-psychiatrist collaboration Psychiatric clinical pharmacist Psychopharmacology expertise Shared decision-making

Journal

Therapie
ISSN: 1958-5578
Titre abrégé: Therapie
Pays: France
ID NLM: 0420544

Informations de publication

Date de publication:
Historique:
received: 24 06 2020
accepted: 20 07 2020
pubmed: 29 12 2020
medline: 18 9 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

The importance of clinical psychopharmacological knowledge for modern psychiatric care is both well-established and underdeveloped. Although psychiatric pharmacists are identified as experts in psychopharmacotherapy based on pharmacists' overall expertise in pharmacotherapy, in real-life health settings, such is not necessarily the case. As a matter of fact, (1) pharmacists' real expertise in pharmacotherapy is mainly seen as useful to patients (as part of therapeutic education), (2) pharmacists' practice methods are usually circumscribed to the framework of quality processes (e.g. comprehensive medication management) which are not particularly useful to clinicians who have a greater need for pharmacotherapeutic skills, (3) the difficulties in terms of collaboration between pharmacists and physicians are well-known. We describe here the implementation of an alternative system of pharmacotherapy counselling inspired by case by cases in which the remote expertise of pharmacists in psychopharmacology guided prescribers towards the implementation of recommendations from the literature. This shared decision-making process integrates both the clinical elements provided by the psychiatrist and the pharmacotherapeutic information provided by the clinical psychopharmacist, to promote evidence-based medicine (algorithmic data in recommendations) and tailor-made solutions (drug-drug and drug-disease interactions) for patients. In our experience, the success of such an initiative is likely to promote the development of clinical psychopharmacology in psychiatric settings. Importantly, within this framework, the pharmacovigilance unit and psychopharmacologist are useful resources to guide the decision-making process of the pharmacist-psychiatrist duo.

Identifiants

pubmed: 33358640
pii: S0040-5957(20)30228-6
doi: 10.1016/j.therap.2020.12.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-156

Informations de copyright

Copyright © 2020 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Hervé Javelot (H)

Établissement public de santé Alsace Nord, Établissement public de Santé mentale Alsace Nord (EPSAN), 67170 Brumath, France; UR 7296 laboratoire de toxicologie et pharmacologie neuro cardiovasculaire, université de Strasbourg, 67000 Strasbourg, France. Electronic address: herve.javelot@ch-epsan.fr.

Sophie Dizet (S)

Centre de ressources et d'expertise en psychopharmacologie (CREPP) Bourgogne Franche-Comté et service pharmacie, CHS de Sevrey, 71100 Chalon sur Saône, France.

Céline Straczek (C)

Département de pharmacie, CHU Henri Mondor, 94000 Créteil, France; Institut Mondor de recherche biomédicale, Inserm U955, équipe 15 neuropsychiatrie translationnelle, 94000 Créteil, France.

Bastien Langrée (B)

Service pharmacie, centre hospitalier Guillaume Régnier, 35000 Rennes, France.

Bruno Michel (B)

Department of pharmacy, university hospital of Strasbourg, NHC, 67000 Strasbourg, France; Faculty of pharmacy, university of Strasbourg, 67000 Strasbourg, France; UR 7296 laboratory of neuro-cardiovascular pharmacology and toxicology, university of Strasbourg, 67000 Strasbourg, France.

Emmanuel Haffen (E)

Service de psychiatrie, CIC-1431 INSERM, CHU de Besançon, 25000 Besançon, France; Laboratoire de neurosciences, université de Franche-Comté, 25000 Besançon, France.

Gilles Bertschy (G)

Pôle de psychiatrie, santé mentale & addictologie des hôpitaux universitaires de Strasbourg, 67000 Strasbourg, France; Inserm U1114, 67000 Strasbourg, France; Fédération de médecine translationnelle de Strasbourg, université de Strasbourg, 67000 Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH